Literature DB >> 17989126

Preoperative management of the pheochromocytoma patient.

Karel Pacak1.   

Abstract

Pheochromocytomas are rare neuroendocrine tumors with a highly variable clinical presentation, but they most commonly present as spells of headaches, sweating, palpitations, and hypertension. Patients with pheochromocytoma may develop complicated and potentially lethal cardiovascular and other complications, especially in the setting of diagnostic or interventional procedures (e.g. upon induction of anesthesia or during surgery). The serious and potentially lethal nature of such complications is due to the potent effect of paroxysmal release of catecholamines. Because this warrants prompt diagnosis and treatment, the physician should be aware of the clinical manifestations and complications of catecholamine excess and be able to provide proper preoperative management to minimize catecholamine-related pre-, intra-, and postoperative adverse events. The following clinical scenario and discussion aim to enhance the knowledge of the physician regarding the behavior of pheochromocytoma and to outline current approaches to comprehensive preoperative management of patients suffering from this tumor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17989126     DOI: 10.1210/jc.2007-1720

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  119 in total

1.  Surgery: Risks of hemodynamic instability in pheochromocytoma.

Authors:  Graeme Eisenhofer; Stefan R Bornstein
Journal:  Nat Rev Endocrinol       Date:  2010-06       Impact factor: 43.330

2.  Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO).

Authors:  Henri J L M Timmers; Graeme Eisenhofer; Jorge A Carrasquillo; Clara C Chen; Millie Whatley; Alexander Ling; Karen T Adams; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-05       Impact factor: 3.478

3.  SAGES guidelines for minimally invasive treatment of adrenal pathology.

Authors:  Dimitrios Stefanidis; Melanie Goldfarb; Kent W Kercher; William W Hope; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

4.  Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method.

Authors:  Nils Habbe; Florian Ruger; Jorg Bojunga; Wolf Otto Bechstein; Katharina Holzer
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

5.  Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior.

Authors:  Hans K Ghayee; Bas Havekes; Eleonora P M Corssmit; Graeme Eisenhofer; Stephen R Hammes; Zahid Ahmad; Alexander Tessnow; Ivica Lazúrová; Karen T Adams; Antonio T Fojo; Karel Pacak; Richard J Auchus
Journal:  Endocr Relat Cancer       Date:  2008-12-15       Impact factor: 5.678

Review 6.  Update on pediatric pheochromocytoma.

Authors:  Bas Havekes; Johannes A Romijn; Graeme Eisenhofer; Karen Adams; Karel Pacak
Journal:  Pediatr Nephrol       Date:  2008-06-20       Impact factor: 3.714

7.  Predictors of hemodynamic instability during surgery for pheochromocytoma.

Authors:  Colleen M Kiernan; Liping Du; Xi Chen; James T Broome; Chanjuan Shi; Mary F Peters; Carmen C Solorzano
Journal:  Ann Surg Oncol       Date:  2014-06-18       Impact factor: 5.344

8.  The Author's Reply: inappropriate adrenoreceptor blockade prior to pheochromocytoma removal - 'A timely reappraisal'.

Authors:  Henrique V Luiz; Run Yu; Katherine Wolf; Ning Miao; Andrew Mannes; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2016-10-03       Impact factor: 3.478

9.  WHY TAKE THE RISK? WE ONLY LIVE ONCE: THE DANGERS ASSOCIATED WITH NEGLECTING A PRE-OPERATIVE ALPHA ADRENOCEPTOR BLOCKADE IN PHEOCHROMOCYTOMA PATIENTS.

Authors:  Katherine I Wolf; Jenn Rachelle U Santos; Karel Pacak
Journal:  Endocr Pract       Date:  2018-10-05       Impact factor: 3.443

10.  Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma.

Authors:  Edwin W Lai; Shiromi M Perera; Bas Havekes; Henri J L M Timmers; Frederieke M Brouwers; Beverly McElroy; Karen T Adams; Shoichiro Ohta; Robert A Wesley; Graeme Eisenhofer; Karel Pacak
Journal:  Endocrine       Date:  2008-11-04       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.